https://www.khondrion.com https://www.khondrion.com/about-us https://www.khondrion.com/our-science https://www.khondrion.com/our-focus https://www.khondrion.com/patients-families https://www.khondrion.com/partnering https://www.khondrion.com/news https://www.khondrion.com/contact https://www.khondrion.com/disclaimer https://www.khondrion.com/privacy-statement https://www.khondrion.com/video/about-us https://www.khondrion.com/video/rd https://www.khondrion.com/khenerfin https://www.khondrion.com/khenerfin/study-locations https://www.khondrion.com/news/2020---a-year-in-review https://www.khondrion.com/news/2021---a-year-in-review https://www.khondrion.com/news/2022-year-in-review https://www.khondrion.com/news/a-coffee-with-the-scientific-advisory-board-prof-dr-anu-suomalainen-wartiovaara https://www.khondrion.com/news/a-coffee-with-the-scientific-advisory-board-prof-dr-marni-falk https://www.khondrion.com/news/a-coffee-with-the-scientific-advisory-board-prof-dr-michelangelo-mancuso https://www.khondrion.com/news/a-coffee-with-the-scientific-advisory-board-prof-dr-shamima-rahman https://www.khondrion.com/news/a-coffee-with-the-scientific-advisory-board-sir-prof-dr-emeritus-doug-turnbull-chairman https://www.khondrion.com/news/bio-europe-2018-interview-with-mike-ward-chief-content-officer-at-informa-pharma-insights https://www.khondrion.com/news/ceo-jan-smeitink-on-khondrions-development-program-and-plans-for-2020 https://www.khondrion.com/news/clarifying-the-phenotypic-spectrum-of-m-3243a-g-a-proposal-for-terminological-precision-in-pmd https://www.khondrion.com/news/clinical-trial-phase-1 https://www.khondrion.com/news/disease-spotlight-cognition-and-mitochondrial-disease https://www.khondrion.com/news/disease-spotlight-leigh-disease https://www.khondrion.com/news/disease-spotlight-maternally-inherited-diabetes-and-deafness https://www.khondrion.com/news/efro-grant-to-support-the-khenergyc-study https://www.khondrion.com/news/ema-orphan-drug-designation https://www.khondrion.com/news/ema-orphan-drug-designation-for-melas-syndrome https://www.khondrion.com/news/eurohealth-leaders-magazine-interviewed-khondrions-ceo-jan-smeitink https://www.khondrion.com/news/fda-orphan-drug-designation https://www.khondrion.com/news/interview-pharmaboardroom https://www.khondrion.com/news/interview-with-herma-renkema-chief-early-development-officer-at-khondrion https://www.khondrion.com/news/interview-with-julien-beyrath-chief-scientific-officer-at-khondrion https://www.khondrion.com/news/interview-with-tom-pulles-chief-medical-officer-at-khondrion https://www.khondrion.com/news/jan-smeitink-interview-with-catalyze https://www.khondrion.com/news/kh176-phase-1-clinical-trials https://www.khondrion.com/news/kh176-phase-2-clinical-trial https://www.khondrion.com/news/kh176-published-in-scientific-reports https://www.khondrion.com/news/khenergy-completion-of-recruitment-and-first-in-patient-dosing https://www.khondrion.com/news/khondrion-and-amsterdam-umc-announce-to-initiate-phase-2-clinical-trial-of-sonlicromanol-to-combat-long-term-post-covid-symptoms https://www.khondrion.com/news/khondrion-and-medvisis-announce-exclusive-licensing-agreement https://www.khondrion.com/news/khondrion-announces-first-patient-dosed-in-pivotal-phase-3-khenerfin-study-of-sonlicromanol-in-mitochondrial-dna-3243a-g-primary-mitochondrial-disease https://www.khondrion.com/news/khondrion-announces-first-patients-dosed-in-6-month-paediatric-phase-ii-study-of-sonlicromanol-for-mitochondrial-diseases https://www.khondrion.com/news/khondrion-announces-first-patients-dosed-in-khenerext-phase-iib-extension-study-examining-long-term-safety-and-efficacy-of-oral-sonlicromanol-in-mitochondrial-disease-patients https://www.khondrion.com/news/khondrion-announces-first-patients-dosed-in-phase-iib-study-of-sonlicromanol-for-mitochondrial-diseases https://www.khondrion.com/news/khondrion-announces-grant-of-patents-in-the-us-and-europe-for-its-lead-candidate-sonlicromanol-covering-the-anti-inflammatory-effect-on-mpges-1 https://www.khondrion.com/news/khondrion-announces-new-scientific-advisory-board https://www.khondrion.com/news/khondrion-announces-publication-in-brain-of-integrated-phase-2b-program-demonstrating-disease-modifying-potential-of-sonlicromanol-in-primary-mitochondrial-disease https://www.khondrion.com/news/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanols-active-metabolite https://www.khondrion.com/news/khondrion-announces-publication-in-scientific-reports-outlining-an-additional-anti-inflammatory-mode-of-action-for-its-lead-phase-iib-stage-drug-candidate-sonlicromanol https://www.khondrion.com/news/khondrion-announces-sonlicromanol-phase-iib-progress-supporting-phase-iii-development-in-melas-spectrum-disorders https://www.khondrion.com/news/khondrion-appoints-herma-renkema-as-chief-early-development-officer https://www.khondrion.com/news/khondrion-appoints-jasper-levink-as-chief-financial-and-business-officer https://www.khondrion.com/news/khondrion-appoints-jasper-levink-as-new-ceo-to-lead-next-phase-of-growth https://www.khondrion.com/news/khondrion-appoints-rob-van-maanen-as-chief-medical-officer https://www.khondrion.com/news/khondrion-appoints-tom-pulles-md-as-chief-medical-officer https://www.khondrion.com/news/khondrion-awarded-h2020-sme-instrument-grant https://www.khondrion.com/news/khondrion-becomes-partner-in-dusra-voila-collaboration https://www.khondrion.com/news/khondrion-completes-enrollment-in-khenergyze-phase-iib-trial-evaluating-sonlicromanol-in-adult-patients-with-melas-spectrum-disorders https://www.khondrion.com/news/khondrion-features-in-new-video-from-catalyze-group-r https://www.khondrion.com/news/khondrion-granted-orphan-drug-designation-for-kh176-for-the-treatment-of-midd-from-european-commission https://www.khondrion.com/news/khondrion-highlights-potential-role-of-inflammatory-lipid-modulator-prostaglandin-e2-in-covid-19-disease https://www.khondrion.com/news/khondrion-is-collaborating-globally-on-its-way-to-market https://www.khondrion.com/news/khondrion-joins-consortium-researching-metabolomic-processes-to-predict-and-prevent-covid-19 https://www.khondrion.com/news/khondrion-joins-the-nadis-international-student-training-network https://www.khondrion.com/news/khondrion-moves-headquarters-to-novio-tech-campus-to-support-growth https://www.khondrion.com/news/khondrion-partner-in-remix-eu-research-project https://www.khondrion.com/news/khondrion-presents-phase-ii-khenergy-trial-data https://www.khondrion.com/news/khondrion-receives-ema-agreement-on-its-paediatric-investigation-plan-for-sonlicromanol https://www.khondrion.com/news/khondrion-receives-fda-clearance-of-ind-application-for-pivotal-phase-3-clinical-trial-of-sonlicromanol-for-the-treatment-of-primary-mitochondrial-disease https://www.khondrion.com/news/khondrion-receives-rare-pediatric-disease-designation-for-sonlicromanol-from-us-fda https://www.khondrion.com/news/khondrion-secures-eu-orphan-drug-designation-for-lead-compound-sonlicromanol-in-treatment-of-inherited-mitochondrial-oxidative-phosphorylation-defects https://www.khondrion.com/news/khondrion-secures-up-to-eu5-million-innovation-credit-from-dutch-government-plus-additional-funding-from-current-investors-to-advance-phase-3-clinical-trial-in-m-3243a-g-primary-mitochondrial-disease https://www.khondrion.com/news/khondrion-shares-progress-of-sonlicromanol-development-programme-at-mitochondrial-medicine-2020-virtual-conference https://www.khondrion.com/news/khondrion-strengthens-executive-team-with-coo-arnout-ploos-van-amstel https://www.khondrion.com/news/khondrion-strengthens-governance-with-appointment-of-experienced-supervisory-board https://www.khondrion.com/news/khondrion-to-attend-umdf-mitochondrial-medicine-symposium-2021 https://www.khondrion.com/news/khondrion-to-participate-in-mitocons-11th-italian-meeting-on-mitochondrial-diseases https://www.khondrion.com/news/khondrion-to-participate-in-mitonice-international-congress-dedicated-to-mitochondrial-medicine https://www.khondrion.com/news/khondrion-to-participate-in-the-16th-annual-dutch-inborn-error-meeting-and-the-united-mitochondrial-disease-foundation-umdf-bench-to-bedside-seminar https://www.khondrion.com/news/khondrion-to-participate-in-world-mitochondria-societys-targeting-mitochondria-2022-congress https://www.khondrion.com/news/khondrion-to-present-at-mito2i-inaugural-research-symposium-on-mitochondrial-medicine-and-research https://www.khondrion.com/news/khondrion-to-present-at-mitocons-10th-italian-meeting-on-mitochondrial-diseases https://www.khondrion.com/news/khondrion-to-present-at-mitocons-14th-mitochondrial-disease-conference https://www.khondrion.com/news/khondrion-to-present-promising-advances-in-mitochondrial-disease-therapy-at-bio-europe-and-investival-showcase-events https://www.khondrion.com/news/khondrion-welcomes-hans-schikan https://www.khondrion.com/news/khondrion-will-present-first-results-of-khenergy-study https://www.khondrion.com/news/mitochondrial-disease-heterogeneity https://www.khondrion.com/news/mitochondrial-medicine-2019 https://www.khondrion.com/news/movement-disorders-in-children-with-primary-mitochondrial-disease https://www.khondrion.com/news/new-cmo-joins-khondrion https://www.khondrion.com/news/new-patents-granted-for-kh176 https://www.khondrion.com/news/new-year-brings-new-look-at-khondrion-com https://www.khondrion.com/news/patient-perspective-a-conversation-with-elja-van-der-veer---former-imp-chair https://www.khondrion.com/news/patient-perspective-a-conversation-with-elja-van-der-veer---former-imp-chair-0ff07 https://www.khondrion.com/news/patient-perspective-a-conversation-with-kasey-woleben---co-founder-and-sophia-zilber---board-member-patient-registry-director-cure-mito-foundation https://www.khondrion.com/news/patient-perspective-a-conversation-with-kate-murray---ceo-and-president-mitocanada https://www.khondrion.com/news/patient-perspective-a-conversation-with-paulien https://www.khondrion.com/news/patient-perspective-a-conversation-with-sams-mother https://www.khondrion.com/news/patient-perspective-a-conversation-with-sean-murray---ceo-the-mito-foundation https://www.khondrion.com/news/publication-of-the-khenergy-study-results https://www.khondrion.com/news/q-a-with-rob-van-maanen https://www.khondrion.com/news/reflections-on-ssiem-annual-symposium-2019---building-bridges https://www.khondrion.com/news/reflections-on-the-mitochondrial-medicine-2019-conference https://www.khondrion.com/news/scientific-publication-in-cell-death-disease https://www.khondrion.com/news/umdf-and-khondrion-announce-the-mito-funds-investment-in-khondrion-to-support-development-of-one-of-the-most-advanced-drug-candidates-for-primary-mitochondrial-disease